What is the size of the Microbial Fermentation APIs market in 2023?

The Microbial Fermentation APIs market size is USD 61.2 billion in 2023.

What is the projected CAGR at which the Microbial Fermentation APIs market is expected to grow at?

The Microbial Fermentation APIs market is expected to grow at a CAGR of 1.5% (2024-2033).

List the key industry players of the Microbial Fermentation APIs market?

Danone UK, DSM, Topfond Pharmaceutical Co. Ltd., KOLON LIFE SCIENCE, Lonza, AbbVie Inc., BASF, Lukang Pharmaceutical

Which region is more appealing for vendors employed in the Microbial Fermentation APIs market?

North America is expected to account for the highest revenue share of 35% and boasting an impressive market value of USD 21.4 billion. Therefore, the Microbial Fermentation APIs industry in North America is expected to garner significant business opportunities over the forecast period.

Name the key areas of business for Microbial Fermentation APIs?

The US, Canada, India, China, UK, Japan, & Germany are key areas of operation for the Microbial Fermentation APIs Market.

Global Microbial Fermentation APIs Market Analysis By Type (Antibiotics, Amino acids, Nucleotide, Organic Acid, Biological Products, Vitamin, Other Types), By End User (Pharmaceutical Companies, Biopharmaceutical Companies, Contract Research Organizations (CROs), Other End-Users), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Feb 2024
Report ID: 21912
Number of Pages: 267
Format:

- 1. Microbial Fermentation APIs Market Introduction
  - 1.1. Definition
  - 1.2. Taxonomy
  - 1.3. Research Scope
- 2. Executive Summary
  - 2.1. Key Findings by Major Segments
  - 2.2. Top strategies by Major Players
- 3. Global Microbial Fermentation APIs Market Overview
  - 3.1. Microbial Fermentation APIs Market Dynamics
    3.1.1. Drivers
    3.1.2. Opportunities
    3.1.3. Restraints
    3.1.4. Challenges
  - 3.2. PESTLE Analysis
  - 3.3. Opportunity Map Analysis
  - 3.4. PORTER'S Five Forces Analysis
  - 3.5. Market Competition Scenario Analysis
  - 3.6. Product Life Cycle Analysis
  - 3.7. Opportunity Orbits
  - 3.8. Manufacturer Intensity Map
- 4. Global Microbial Fermentation APIs Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
  - 4.1. Global Microbial Fermentation APIs Market Analysis by Type: Introduction
  - 4.2. Market Size and Forecast by Region
  - 4.3. Antibiotics
  - 4.4. Amino acids
  - 4.5. Vitamin
  - 4.6. Nucleotide
  - 4.7. Organic acid
  - 4.8. Alcohol
  - 4.9. Biological products
  - 4.10. Hormone
- 5. Global Microbial Fermentation APIs Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
  - 5.1. Global Microbial Fermentation APIs Market Analysis by Application: Introduction
  - 5.2. Market Size and Forecast by Region
  - 5.3. Hospitals
  - 5.4. Research & Academic Laboratories
  - 5.5. Pharmaceutical & Biotechnology Companies
- 6. Global Microbial Fermentation APIs Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
  - 6.1. North America
    6.1.1. North America Microbial Fermentation APIs Market: Regional Trend Analysis
    6.1.1.1. US
    6.1.1.2. Canada
    6.1.1.3. Mexico
  - 6.2. Europe
    6.2.1. Europe Microbial Fermentation APIs Market: Regional Trend Analysis
    6.2.1.1. Germany
    6.2.1.2. France
    6.2.1.3. UK
    6.2.1.4. Russia
    6.2.1.5. Italy
    6.2.1.6. Rest of Europe
  - 6.3. Asia-Pacific
    6.3.1. Asia-Pacific Microbial Fermentation APIs Market: Regional Trend Analysis
    6.3.1.1. China
    6.3.1.2. Japan
    6.3.1.3. Korea
    6.3.1.4. India
    6.3.1.5. Rest of Asia
  - 6.4. Latin America
    6.4.1. Latin America Microbial Fermentation APIs Market: Regional Trend Analysis
    6.4.1.1. Brazil
    6.4.1.2. Argentina
    6.4.1.3. Rest of Latin America
  - 6.5. Middle East and Africa
    6.5.1. Middle East and Africa Microbial Fermentation APIs Market: Regional Trend Analysis
    6.5.1.1. GCC
    6.5.1.2. South Africa
    6.5.1.3. Israel
    6.5.1.4. Rest of MEA
- 7. Global Microbial Fermentation APIs Market Competitive Landscape, Market Share Analysis, and Company Profiles
  - 7.1. Market Share Analysis
  - 7.2. Company Profiles
  - 7.3. Merck
    7.3.1. Company Overview
    7.3.2. Financial Highlights
    7.3.3. Product Portfolio
    7.3.4. SWOT Analysis
    7.3.5. Key Strategies and Developments
  - 7.4. Ajinomoto
    7.4.1. Company Overview
    7.4.2. Financial Highlights
    7.4.3. Product Portfolio
    7.4.4. SWOT Analysis
    7.4.5. Key Strategies and Developments
  - 7.5. HGPF
    7.5.1. Company Overview
    7.5.2. Financial Highlights
    7.5.3. Product Portfolio
    7.5.4. SWOT Analysis
    7.5.5. Key Strategies and Developments
  - 7.6. Huaxing
    7.6.1. Company Overview
    7.6.2. Financial Highlights
    7.6.3. Product Portfolio
    7.6.4. SWOT Analysis
    7.6.5. Key Strategies and Developments
  - 7.7. North China Pharmaceutical
    7.7.1. Company Overview
    7.7.2. Financial Highlights
    7.7.3. Product Portfolio
    7.7.4. SWOT Analysis
    7.7.5. Key Strategies and Developments
  - 7.8. Topfond
    7.8.1. Company Overview
    7.8.2. Financial Highlights
    7.8.3. Product Portfolio
    7.8.4. SWOT Analysis
    7.8.5. Key Strategies and Developments
  - 7.9. DSM
    7.9.1. Company Overview
    7.9.2. Financial Highlights
    7.9.3. Product Portfolio
    7.9.4. SWOT Analysis
    7.9.5. Key Strategies and Developments
  - 7.10. Tianyao
    7.10.1. Company Overview
    7.10.2. Financial Highlights
    7.10.3. Product Portfolio
    7.10.4. SWOT Analysis
    7.10.5. Key Strategies and Developments
  - 7.11. CSPC Pharma
    7.11.1. Company Overview
    7.11.2. Financial Highlights
    7.11.3. Product Portfolio
    7.11.4. SWOT Analysis
    7.11.5. Key Strategies and Developments
  - 7.12. Northeast Pharm
    7.12.1. Company Overview
    7.12.2. Financial Highlights
    7.12.3. Product Portfolio
    7.12.4. SWOT Analysis
    7.12.5. Key Strategies and Developments
  - 7.13. Lukang Pharmaceutical
    7.13.1. Company Overview
    7.13.2. Financial Highlights
    7.13.3. Product Portfolio
    7.13.4. SWOT Analysis
    7.13.5. Key Strategies and Developments
  - 7.14. Luwei Pharmaceutical
    7.14.1. Company Overview
    7.14.2. Financial Highlights
    7.14.3. Product Portfolio
    7.14.4. SWOT Analysis
    7.14.5. Key Strategies and Developments
  - 7.15. Jiangshan (DSM)
    7.15.1. Company Overview
    7.15.2. Financial Highlights
    7.15.3. Product Portfolio
    7.15.4. SWOT Analysis
    7.15.5. Key Strategies and Developments
- 8. Assumptions and Acronyms
- 9. Research Methodology
- 10. Contact
- Danone UK
- DSM
- Topfond Pharmaceutical Co. Ltd.
- KOLON LIFE SCIENCE
- Lonza Group AG Company Profile
- AbbVie Inc. Company Profile
- BASF SE Company Profile
- Lukang Pharmaceutical
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)